Combined inhalation of steroid, beta2 stimulant,and neophyllin after lung resection: safety and feasibility study

Combined inhalation of steroid, beta2 stimulant,and neophyllin after lung resection: safety and feasibility study - Combined inhalation of steroid, beta2 stimulant,and neophyllin after lung resection: safety and feasibility study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006885

Enrollment

Registered

2011-12-21

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing lung resection for cancer or benign diseases

Interventions

inhalation of steroid, beta2 stimulant and neophyllin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)lung resection is planned 2)Performance status 0-1 3)sustained organ function 4)able to tolerate general anesthesia 5)written consent is obtained

Exclusion criteria

Exclusion criteria: a)presence of background lung diseases b)allergy to any of the inhalation drugs c)pregnant or lactating d)history of cardiac disease e)patients whom doctors judged inadequate to the enrollment of this study by other reasons

Design outcomes

Primary

Measure	Time frame
Safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026